Pharmacovigilance – Products
Cytel Appoints New VP Scientific Strategy & Innovation To Further Drive Bayesian Innovation
Cytel Inc. is pleased to announce that renowned Bayesian clinical trial design specialist Dr Kyle Wathen has joined Cytel as Vice President of Scientific Strategy and Innovation.
Cmed Group Joins AIXIAL, the CRO of ALTEN Group
AIXIAL, the CRO of ALTEN Group, announces the acquisition of UK headquartered CMED Group by ALTEN EUROPE.
The FDA Expands Collaboration With CN Bio To Investigate Lung-on-a-Chip Model for Inhaled Drug Evaluation Applications
CN Bio has announced that the U.S. Food and Drug Administration (FDA) has extended their research collaboration for a further three years.
GenNext Technologies Announces Protein Footprinting Patent for Breakthrough Technology
GenNext Technologies, Inc., has announced that nearly $7M in NIH grant awards has led to a seminal US patent for its novel technology that vastly improves the utility of protein footprinting for the study of biopharmaceutical higher-order structure.
Cambridge Crystallographic Data Centre Simplifies Management of Complex Crystal Structure Prediction (CSP) Data
The Cambridge Crystallographic Data Centre (CCDC) announces the launch of CSD-Theory software for use in small molecule pharmaceutical development. This latest addition to the CCDC’s software toolbox delivers easy storage, management, search and display of crystal structure prediction results alongside experimental structures on a web-based platform and an API interface.
ENPICOM and Viroclinics-DDL Partner To Accelerate and Improve Antibody and Vaccine Discovery and Development
Viroclinics-DDL and ENPICOM have announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application.
Minimize Cost and Maintain Quality in Drug Discovery
Waters Announces New Method Workflow to Help Meet Regulatory Requirement
Waters Corporation has introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists to monitor efficacy and safety through the analysis of critical quality attributes (CQAs) of monoclonal antibodies (mAbs) and other protein-based drugs.
Solutions for Host Cell Protein Analysis
Download this whitepaper to discover approaches for the detection and quantification of HCPs that streamline the process of impurity monitoring, have broad sample applicability through mass spectrometry and consider patient safety, product stability and purity.
APN01 Shows Clinical Benefit for Severely Ill COVID-19 Patients in Phase II Trial
APEIRON Biologics AG, a privately held biotech company developing breakthrough therapies to treat cancer and respiratory conditions, announced today that APN01 (alunacedase alfa) treatment showed statistically significant improvements in specific areas for severely ill COVID-19 patients.